CHARLOTTE MCKAMEY: Open Payments
NPI 1558106898 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,839 in 108 payments from 39 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,839
Food & beverage: $2,394Education: $445
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $310 |
| Ipsen Biopharmaceuticals, Inc | 3 | $198 |
| ABBVIE INC. | 2 | $173 |
| Regeneron Healthcare Solutions, Inc. | 6 | $170 |
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Lilly USA, LLC | 4 | $137 |
| PFIZER INC. | 7 | $130 |
| SOBI, INC | 5 | $125 |
| Incyte Corporation | 5 | $121 |
| Daiichi Sankyo Inc. | 4 | $117 |
Products named: KEYTRUDA, Venclexta, LIBTAYO, Vonjo, ENHERTU, REBLOZYL, OPDIVO, Orserdu.
Industry payments across FL — which companies pay providers there.
